Sihe Wang is head and director Section of Clinical Biochemistry; medical staff Departments of Clinical Pathology and Nephrology and Hypertension and director Clinical Biochemistry Fellowship Training Program Cleveland Clinic Cleveland Ohio The Clinical Biochemistry Section performs ~15 million tests annually and consists of an automated chemistry laboratory a special chemistry laboratory and various satellite laboratories including a blood gas laboratory Additionally he is clinical professor Cleveland State University where he lectures on special topics in clinical chemistry He received his PhD in pharmacy medicinal chemistry at the University of North Carolina at Chapel Hill He completed a postdoctoral fellowship in clinical chemistry at Duke University Medical Center Durham North Carolina Prior to his current position he was assistant professor at Northwestern University and director Clinical Chemistry Laboratory and Referred Testing Laboratory Children’s Memorial Hospital Chicago IllinoisDr Wang is a diplomate of the American Board of Clinical Chemistry and a fellow of the National Academy of Clinical Biochemistry He is a member of several professional organizations including the American Society for Mass Spectrometry and the American Association for Clinical Chemistry AACC He has served in many capacities in the AACC organizations including the chair of AACC Northeast Ohio Section in 2008 and 2009 and the president of North American Chinese Clinical Chemistry Association 20082009 Dr Wang currently serves as the secretary for the Pediatric and Maternal Fetal Division of AACC The AACC presented him with the 2005 and 2008 Clinical Chemist Recognition Award Dr Wang was also the recipient of the 2006 Lemuel J Bowie Young Investigator Award at the Chicago Section of the American Association of Clinical Chemistry AACC Dr Wang is the author of more than 75 clinical journal articles book chapters abstracts and meeting presentations He has also lectured in the US and around the world on variety of clinical chemistry topics He has been a principal investigator or coinvestigator in several trials to evaluate and validate new testing technologies and novel tests.

Clinical chemistry, Mass Spectrometry.

Professor, Environmental Engineering, London South Bank University.

Chromatography, DNA sequencing, gel electrophoresis, NMR.

Dr. Wayne Grant Carter received his Honours degree in Biochemistry with Nutrition from the University of Southampton. He then completed a PhD at the University of Southampton studying the molecular signalling cascade elicited by insulin. His PhD studies encompassed the design and synthesis of peptide targets for insulin stimulated kinases and their utilisation to dissect signalling events downstream of insulin binding to its receptor He purified peptide targets by reversephase high performance liquid chromatography RPHPLC and assayed signalling kinases utilising radiolabelled phosphorus to determine phosphorylation sites by both radiosequencing and phosphopeptide mapping eg Carter et al 1995 1996 Subsequent postdoctoral studies at the Babraham Institute Cambridge; Imperial College London; University of California at Irvine; and University of Oxford were also directed toward the regulation of cellular signalling mechanisms through posttranslational modification of proteins and how these influence inflammation and homeostasis Dr Carter then spent one year working for Mobious Genomics Exeter assisting with the biophysical development of novel DNA sequencing devices before he joined the staff at the University of Nottingham where he is currently a Principal Investigator and Lecturer for a new course in Healthcare Sciences founded at the University of Nottingham site within the Royal Derby Hospital Derby His previous and current research pioneered the use of proteomic techniques coupled to novel imaging of radiolabels to detect and purify proteins that are modified posttranslationally eg Vigneswara et al 2006; Carter et al 2007; Tarhoni et al 2008; Carter Aswad 2008; Kharbanda et al 2009; Carter et al 2010 He has received external grant funding for his academic studies from research funding bodies that include the Wellcome Trust UK and the National Institutes of Health USA and also from commercial sources that include Syngenta UK His professional affiliations include The Physiological Society the Royal Society of Chemistry the Biochemical Society the British Toxicological Society the British Neuroscience Association and the American College of Sports Medicine He has peerreviewed manuscripts for numerous academic journals including: FEBS Letters Brain Research Environmental Toxicology Biochemica et Biophysica Acta American Journal of Physiology Journal of Chromatography B International Journal of Biomedical Science World Journal of Cardiology and Toxicological Sciences and is currently an Editorial Board member for the World Journal of Biological Chemistry as well as Executive Editor for Europe for the Journal of Chromatography Separation Techniques

Purified peptide targets by reverse-phase high performance liquid chromatography (RP-HPLC), and assayed signalling kinases utilising radiolabelled phosphorus to determine phosphorylation sites by both radiosequencing and phosphopeptide mapping. Use of proteomic techniques coupled to novel imaging of radiolabels to detect and purify proteins that are modified post-translationally.

Prof. Marcello Nicoletti has received his PhD in Chemistry at the University of La Sapienza of Rome, Italy during the period of 1970-75. Currently he is working as full professor in the University of La Sapienza of Rome. He is serving as an editorial member,referee for several reputed journals like Natural Product Reports, Plant Biosystem Natural Products, Communication Analytical Letters and others. He has authored more than 100 research articles, books. He is a member of Italian Phytochemical Society vicepresident SILAE Italian Pharmacognosy Society. He has honored as consultant expert of EMA

Natural products chemistry, phytochemistry, analytical studies.

Dr. Hobbs is originally from Evansville, Indiana, and earned his bachelor’s and master’s degrees in biology from Indiana State University in Terre Haute. He earned his doctorate in Biochemistry at Oklahoma State University in Stillwater, with a thesis entitled, “Organization and In Vitro Translation of Maize Chlorotic Mottle Virus RNA”. He completed Postdoctoral training at SUNY Stony Brook in the laboratory of Dr. Melvin V. Simpson, working on the toxicity of dideoxynucleosides and the role of mitochondria. Dr. Hobbs completed a fellowship in clinical chemistry at the University of Louisville School of Medicine which included both clinical and research responsibilities. He has held positions with numerous commercial laboratory firms and is currently Technical Director, Toxicology, Quest Diagnostics, Inc. in Cambridge Mass. He is a member of the American Association for Clinical Chemistry and a fellow of the National Academy of Clinical Biochemistry.

Chromatographic analysis of drugs of abuse and clinical correlations.

Francesco Addeo hasreceived PhD at Manchester. currently working as Professor in Environmental Engineering at London South Bank University

Introduction to Environmental Pollution Measuring Contamination Marine Pollution and Impacts.

Dr. Schinazi received his PhD in Chemistry from the University of Bath England in 1976. He is the Frances Winship Walters Professor of Pediatrics and Director of the Laboratory of Biochemical Pharmacology at Emory University. He also serves as the Senior Research Career Scientist at the Atlanta Department of Veterans Affairs and coDirector of the Virology/Drug Discovery Core for the NIH sponsored Emory University Center for AIDS Research CFAR Dr Schinazi is on the editorial member of several reputed journals including Antiviral Research AIDS Reviews Antiviral Chemistry and Chemotherapy Global Antiviral Journal Antiviral Therapy HIV/AIDS  Research and Palliative Care and Open Access Journal of Hepatology. He has authored over 430 peer reviewed papers and seven books and has secured more than 90 issued US patents. Dr. Schinazi is the recipient of numerous awards including the Georgia Biomedical Industry Growth Award the Bruce Witte Annual Distinguished Award and the 2006 Distinguished Scientist Award from the Hepatitis B Foundation the Ewing Marion Kauffman Foundation Top Innovators in America Award and two Merit Awards from NIHNIAID In 2006 he received an honorary DSc from the University of Bath for his research accomplishments in the field of HIV and biotechnology He also served on the Presidential Commission on AIDS

Dr. Schinazi research focuses on developing treatments for infections caused by human immunodeficiency viruses, herpesviruses, HBV, HCV, Dengue virus, XMRV and Cryptosporidium parvum.

BSc in Pharmacy from Gifu Pharmaceutical University, Msc from Gifu Pharmaceutical University

Pharmaceutical Analytical Chemistry, Pharmaceutical Sciences.

Dr. Dana Boyd Barr has received PhD in Analytical Chemistry from Georgia State University in1994.Currently she is working as Research Professor in the Department of Environmental Health

Interested in such as fluorescence quantum yield determination, dye stability, DNA melting temperatures, and fluorescence detection limit studies on near-infrared fluorophores and their bioconjugates. Developed methods for covalently linking functionalized cyanine dyes to amino-modified DNA oligomers. Developed methods for purifying cyanine bioconjugates. Acquired extensive experience with high-performance liquid chromatography, DNA sequencing, gel electrophoresis, NMR, IR spectroscopy, lasers, optic design, fluorescence and absorption spectroscopy, and wet chemistry methods.

Paul L Wood has received PhD from Queen`s University; Ontario Canada and BSc from Trent University; Ontario Canada.

Plasmalogen replacement as a therapeutic strategy in Alzheimers disease, Oligodendrocyte cytoprotectants for multiple sclerosis. The role of glutamate toxicity in autism, Endogenous inhibitors of colorectal cancer.

Dr. Patrizia Polverino de Laureto has received her PhD in Pharmaceutical Sciences at the University of Padua, during the period from 1991 to 1993. Currently she is working as researcher at CRIBI Biotechnology Centre of University of Padua and teaches Biochemical Methodologies and Proteomics at the Faculty of Pharmacy Analytical Biochemistry and Methodologies of Functional Genomics Proteomics at the Faculty of Sciences. She has authored 63 full publications, 120 posters and 15 oral communications to Congresses. and she is serving as referee of several reputed journals. She is a member of SIB Italian Society of Biochemistry

Main scientific interests are in the field of protein folding and misfolding, protein chemistry, bio-spectroscopy, mass spectrometry and proteomics. In particular she is interested in the study of the aggregation process of amyloidogenic proteins involved in neurodegeneration and amyloid diseases.

Vladimir I Razinkov received PhD degree in Molecular Biophysics from Moscow Institute of Physics and Technology Russia and completed my post doctoral training in the Rush Medical Center Chicago. I worked on different positions in biopharmaceutical industry including Wyeth and MedImmune. I am currently a Principal Scientist in the Department of Formulation and Analytical Research in Amgen

protein biochemistry and biophysics, characterization of protein structure and protein-protein interactions, development of high throughput analytical methods for early formulation and candidate selection.

Analytical development of bioanalytical methods, Analytical mass Spectrometer

Prof. Jinyong Peng has received his PhD from The Second Military Medical University, Shanghai, China during the period of 2003-2006, and received his post- doctoral degree in Analytical Chemistry from Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China. Currently, he is working as the dean for the Department of Pharmaceutical Analysis, College of Pharmacy, Dalian Medical University. He is serving as an Associate Editor or Editorial Member of more than ten reputed journals. He has published more than 70 research articles. He is a member of Chinese Pharmaceutical Association, Chinese Pharmacological Society, and Chinese Chemical Society. He has honored as “The Award Young Teacher of Fok Ying Tong Education Foundation”, “Access to the Liaoning Provence Science and Technology Advancement Award, Second Class”, “The Award Young Scientist of Dalian.

To develop and establish effective or new high-performance liquid chromatography (HPLC), Gas chromatography (GC), HPLC-MS/MS, nano-RP-HPLC-ESI-MS/MS/ MS, high-speed counter-current chromatography (HSCCC), and some coupling chrom -atographic techniques used for preparation, determination or analysis of pharmaceuticals, natural products, biological samples and proteins.

Professor Ray K Iles has a BSc in analytical biochemistry Kingston University UK MSc in applied immunology Brunel University UK PhD in molecular pathology Barts and the London Medical School UK and professional recognition as a chemist fellow of the Royal Society of Chemistry FRCS and biologist Chartered Biologist – CBiol and Fellow of the Society of Biology FSB Rising rapidly within the strong scientific training ground of Bart’s Medical School he is an internationally recognized medical science academic As a medical educator he is most noted for his contribution to four editions of the world’s best selling text book of Clinical Medicine by Kumar and Clark He has successfully supervised 20 Doctoral Studies and taught and run modules and courses on BSc BMedSci MBBS MSc MRCP and taught doctoral degreesHis track record is of 10 book chapters 90 peer reviewed research papers and four patents He has been an applicant/coapplicant on over 40 research grants

Biomarkers: in particular, with regard to the analysis, genetics, biology and clinical significance of human chorionic gonadotropin.

Dr Shengmin Sang is an Associate Professor in the Center of Excellence for PostHarvest Technologies at North Carolina Agricultural and Technical State Univesity He is also an adjunct faculty in the Department of Chemical Biology School of Pharmacy at Rutgers University and in the Department of Food Bioprocessing and Nutritional Sciences at North Carolina State University He obtained his PhD degree as a natural product chemist from Shanghai Institute of Material Medicine Chinese Academy of Sciences in 1999 He has published 110 peerreviewed articles in reputable journals and 15 book chapters He has coedited a book titled “Herbs: Challenges in Chemistry and Biology” He has also received two US patents Dr Sang’s research has been supported by research grants from NIH US Department of Agriculture private foundations as well as private companies His outstanding research in the area of food and health was recognized by winning year 2007’s Young Scientist Award of the Agricultural and Food Chemistry Division of the American Chemical Society and year 2009’s Matthew Suffness Young Investigator Award which is currently the highest honor for an investigator in the first ten years of his independent research career in the American Society of Pharmacognosy.

Purifying and identifying bioactive components from herbal medicine and functional foods; • Standardization and quality control of herbal medicine and functional foods; • Studying the bioavailability and biotransformation of bioactive food components in animals and humans; • Studying the preventive effects of dietary polyphenols on the development of diabetic complications focusing on the trapping of reactive dicarbonyl compounds and the formation of Advanced Glycation End Products (AGEs) using in vitro and animal models; • Developing new chemopreventive agents from dietary sources using in vitro and animal models.• Using metabolomic approach to study dietary exposure markers.

Prof. Jeffrey Wang received his PhD in Pharmaceutical Sciences from the University of Southern California in 1995 Currently he is an Associate Professor at the College of Pharmacy Western University of Health Sciences in Pomona California He is also an Assistant Director for Bioanalysis and Pharmacokinetics of the Center for the Advancement of Drug Research and Evaluation. He has authored 34 research articles/book chapters and several US and international patents .He is a member of the American Association of Pharmaceutical Scientists American Chemical Society and American Association for Cancer Research

Bioanalysis; Drug discovery; Drug metabolism; Pharmacokinetics; Peptide and protein drug delivery.

1. Biological/biomedical applications of mass spectrometry.
2. Lipidomics, metabolomics, Discovery of novel brain lipids, elucidation of lipid biosynthesis pathway and lipid metabolism.
3. Integrating MS into genetics, identification of substrate of genes with unknown function.
4. Proteomics, characterization of protein post-translational modifications, tandem MS development.
Natural product identification and structural characterization.

He has received PhD from West Virginia University, WVU B Pharm from Birla Institute of Technology BITS India.

Pharmaceutical Evaluation & Policy (PEP)- Radiation Health- Pharmacogenomics.

Dr. Bhagavatula Moorthy has received PhD from indian Institute of Science India in 1988. Currently working as Associate Professor of Pediatrics Neonatology

Molecular mechanisms of lung injury induced by hyperoxia
Molecular regulation of hepatic and pulmonary cytochrome P4501A expression by oxygen, and the role of CYP1A enzymes in oxygen toxicity
Regulation of CYP1A enzymes by polycyclic aromatic hydrocarbons, in relation to chemical carcinogenesis. 
Mechanisms of formation and repair of exogenous and endogenous DNA adducts, and their role in carcinogenesis and oxygen toxicity.

Eva J Helmerhorst has recived PhD from Netherlands and MS from Vrije Universiteit Amsterdam The Netherlands, and BS from Hogeschool van Amsterdam The Netherlands. Currently she is working as Associate Professor at Boston University

Saliva is well known to play a major role in maintaining oral health conditions by interfering with the adverse affects of oral pathogens. My research interests focus on the structure-function relationships of salivary proteins. Most important in this host protection by saliva is the capacity of several salivary proteins to protect oral hard and soft tissues. More recent studies with pure salivary proteins isolated from sterile glandular secretions have shown that functional domains representing short segments of the native proteins also exhibit antimicrobial and mineral homeostasis characteristics. Once these native proteins derived from the glandular secretions enter the oral cavity they are exposed to a host of enzymes including proteases. My projects are specifically geared towards an understanding of the proteolytic fragmentation of these glandular proteins using proteomics approaches for their structural characterization and specific bioassays to evaluate the effects of proteolysis on the functional spectrum of these salivary macromolecules. .

Dr. QingYi Lu is an Associate Professor in the David Geffen School of Medicine University of California at Los Angeles. Dr QingYi Lu has received her PhD in New York University and completed postdoctoral training in Rockefeller University. She has authored more than 40 research articles. She is a reviewer of 10 professional journals including Clinical Cancer Research and JAMA.

Identification of biomarkers for chemoprevention
Bioavailability of dietary chemopreventive agents
Chemoprevention using natural products
Isolation/identification of bioactive components from plants
Gene-nutrient interactions.

Dr. Adamec started his research career in the Institute of Microbiology of the Czech Academy of Sciences, 1991. In 1992 Dr. Adamec joined the PhD program at this Institute and his research was focused mainly on mechanisms of regulation of expression of stress proteins during cell differentiation. After finishing his PhD in 1994 he spent two years in Department of Genetics at Yale University as a postdoctoral fellow working on research problems in metabolic diseases of mitochondrial origin. In 1999 he joined a research group at the Mayo Clinic working on disease mechanisms in Friedreich’s ataxia. In 2002 Dr. Adamec accepted the invitation of the founders to assume the position of Senior Scientist at Beyond Genomics a biopharmaceutical company founded to discover and develop new drugs with Systems Biology approaches. Currently he is working as Research Associate Professor and a Lead Scientist for Proteomics and Metabolomics at the Bindley Bioscience Center at Purdue University. Dr. Adamec has authored more than 40 scientific journal publications. He is also author of three book chapters multiple patents and associated editor Journal of integrated OMICS.

oxidative stress, proteomics, metabolomics, cancer, neurodegenerative diseases, predictive biomarkers.

ZhengXiong Xi has received his PhD in Neuroscience at Medical College of Wisconsin in 2000. Currently he is working as an Associate Scientist at the Neuropsychopharmacology Section National Institute on Drug Abuse NIDA Intramural Research Program IRP. He has authored over 70 research articles,books. He is a member of Society of Neuroscience Society of Neurochemistry and Society of Cannabinoid Research. His major interest is to study the brain neurochemical mechanisms underlying drug addiction and medication development for the treatment of drug addiction and other neuropsychiatric diseases such as depression schizophrenia and Parkinson disease

The brain neurochemical mechanisms underlying drug addiction and medication development for the treatment of drug addiction and other neuropsychiatric diseases such as depression, schizophrenia and Parkinson disease.

Dr. Hirak S Basu received his PhD in 1985 from Indian Institute of Science Bangalore India during the period of 1978-1985. Currently he is working as a Chief Scientific Officer of Colby Pharmaceutical Company Menlo Park CA and also as a Principal Investigator in the University of Wisconsin Madison WI. He has successfully completed his Administrative responsibilities as a reviewer of NIH SBIR cancer drug discovery study section NIH SBIR cancer drug contract study sections. Department of Defense Prostate Cancer drug development study section memberships of the University of Wisconsin Medical School and Graduate School Admissions Committees and in the editorial board of the Journal of Biological Systems. He is currently serving as an editorial member of a the Journal of Translational Research, He has coauthored over 50 peer reviewed research articles and seven book chapters and  review articles He is a member of American Association of Cancer Research and the above mentioned of NIH and DoD grant proposal peer review committees

Mechanism of prostate cancer occurrence, recurrence and progression
Development of new drugs for treatment and prevention of prostate and other cancers
Development of new clinical protocols for treatment of prostate cancer.

Prof. Andrew Ottens received his PhD in Chemistry from the University of Florida and completed his postdoctoral training in Neuroscience at the McKnight Brain Institute. He is currently an Assistant Professor of Anatomy and Neurobiology and Biochemistry at Virginia Commonwealth University Medical College of Virginia. Prof. Ottens is also a member of the editorial advisory board for Expert Review of Proteomics has authored over twenty five research articles and book chapters and recently edited a volume entitled Neuroproteomics  Methods and Protocols. He is a member of the American Chemical Society the American Society for Mass Spectrometry the Society for Neuroscience and the National Neurotrauma Society. Dr. Ottens has been honored with the Bates Award for Excellence in Analytical Chemistry and an NIH Career Quantitative Research Development Award

Prof. Ottens studies the biochemical impact of trauma and toxicity in the brain with an interest in the temporal progression of injury and repair mechanisms and their modulation via treatment. His research involves expertise in neuroproteomics, applying large-scale quantitative methods for temporal characterization of perturbed brain biochemistry. The neuroproteome is perhaps one of the most complex biological mixtures, involving research at the extreme of molecular separations.

Dr. Mark E McComb has received PhD from University of Manitoba Winnipeg MB Canada, and MSc fromUniversity of Manitoba Winnipeg, and MB Canada, BSc from University of Manitoba Winnipeg MB Canada.

His current research focuses on the development of technologies and methods for the elucidation of changes in post-translational modificationsof proteins using a wide variety of mass spectrometry and bioinformatics approaches.

Dr. Dora Il’yasova started her scientific career at Moscow State University where she received MS in biochemistry, She obtained PhD in Epidemiology at the Department of Epidemiology at the University of North Carolina at Chapel Hill UNCCH. As a part of her dissertation she conducted a casecontrol study on rectal cancer and tea consumption in Moscow. This study won the First prize in the 2001 Congress of Epidemiology the Abraham Lilienfield Award As a Fellow in the Cancer Control and Prevention Program Dr. Il’yasova’s joined the Comprehensive Cancer Center at Wake Forest University CCCWFU to study the role of oxidative damage in the development of chronic conditions Her research focused on biomarkers of oxidative status Currently Dr. Il’yasova works at Duke Comprehensive Cancer Center, She conducts multiple studies examining the relationship between urinary biomarkers of oxidative status detection with different chronic disease outcomes. The biomarkers are measured by liquid chromatography with tandem mass spectrometry Dr. Il’yasova actively participated in development of these methods some of which has been clinically validated

Biomarkers and chronic diseases, specifically, biomarkers of oxidative damage.

Dr. Kasumov has received his PhD in organic chemistry at Moscow State University, Russia during the period of 1990-1993. Currently he is working as a staff member in Departments of Gastroenterology Hepatology and Pathobiology at the Cleveland Clinic Foundation. He is also an Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He is serving as an Ad Hoc reviewer for highly reputed journals like Journal of Biological Chemistry and Nature Protocols Dr. Kasumov has authored more than fifty research articles He is a member of American Society of Mass Spectrometry and American Society of Nutrition

 Dynamic proteomics and metabolomics
 Metabolic investigations using stable isotopes.
Obesity, Insulin resistance and Metabolic syndrome
Cardiac ischemia-reperfusion injury: Mechanisms and Protection.
Chromatography and Mass Spectrometry

Dr. Robin Couch has received PhD in Biochemistry University of Calgary Calgary Alberta Canada.  BS in Biochemistry University of Calgary Calgary Alberta Canada.

Investigations for New Drugs-new therapeutics for treating Alzheimers disease and is currently evaluating the effectiveness of neuroprotection. His work involves the use of neurotrophins, molecules that defend brain cells against death. This includes nerve growth factor, a specific neurotrophin that binds to brain cells and promotes their survival.

Dr. Thomas O Metz is a Senior Research Scientist in the Biological Sciences Division of Pacific Northwest National Laboratory located in Richland WA USA. He earned his PhD in Chemistry at the University of South Carolina and subsequently completed a postdoctoral appointment at PNNL. He has published 29 peer reviewed papers and 2 book chapters and is a member of the American Chemical Society American Society for Mass Spectrometry the Metabolomics Society and the International Maillard Reaction Society

Metabolomics and lipidomics methods development and applications in disease and fundamental research; Systems biology; Role of the Maillard reaction in the development of diabetic complications.

ShengSuan Victor Cai received a Bachelor of Science Degree in Chemistry at China Agricultural University in 1984 and a Master of Science Degree in Environmental Science with an emphasis in Analytical Chemistry at Washington State University in 1996. Currently he is working as a Senior Application Scientist in Syagen Technology Inc wwwsyagencom an analytical instrument company located in Tustin California. His current research interest is development of APPI based LCMS/MS method for analysis of a wide range of small molecules such as pharmaceuticals lipids steroids vitamins pesticides PAHs and other environmental pollutants Since joining Syagen in 2003 Mr Cai has authored about a dozen of journal research articles describing APPI technique for LCMS/MS analysis of lipids PAHs and pharmaceutical. He has served as a peer reviewer for several scientific journals including ACS Analytical Chemistry Journal of Chromatography A European Elsevier journal Rapid Communications in Mass Spectrometry European John Wiley Sons journal and Food Chemistry European Elsevier journal etc. He is a member of American Chemical Society ACS and American Society for Mass Spectrometry ASMS

Demonstrated expertise in development and validation of GC/MS and LC/MS/MS analytical methods. In depth knowledge of principles and applications of separation sciences. Extensive experience in interpreting GC-MS and LC-MS/MS generated analytical data. Extensive hands-on experience in operating Waters/Micromass, Agilent, ThermoFisher, Shimazu, Beckman-Coulter, Varian instruments including GC (FID, ECD, NPD, FPD), HPLC (UV, FL, PDA), CE (UV, PDA), CE-MS, GC-EI-MS, LC-MS/MS and UPLC-MS/MS (ESI, APPI, APCI), etc. Extensive hands-on experiences in performing data analyses and reports using software such as Excel, Masslynx, Quanlynx, Xcalibur, HP ChemStation, Target and LIMS, etc. Working knowledge of isotope dilution GC-MS, LC-MS/MS methods for trace bioanalysis of small molecules. Extensive hands-on experience in sample prep., extraction, cleanup and analysis of biological and environmental samples.

Hongliang Jiang is currently a Staff Scientist in the Department of Bioanalytical Chemistry at Covance Laboratories Inc. He has received his PhD in Pharmaceutical Sciences from University of Arizona in 2005. In 2005-2006 he worked as a Postdoctoral research fellow in the field of metabolomics and proteomics at Pacific Northwest National Lab. He is serving as reviewer for Talanta and Journal of Chromatography A. He has authored about 20 research articles in various journals such as Journal of Chromatography A, Journal of Chromatography B, Analytical Chemistry Rapid Communications in Mass Spectrometry and Phytochemistry

Chiral separation, Quantitative analysis of small molecules and proteins in biological samples, Drug metabolism, Metabolomics.

Dr. Bharathi Avula has received PhD from BITS Pilani in INDIA. Currently she is working as Research Scientist In the National Center for Natural Products Research

Development and validation of analytical methods for wide range of botanicals and dietary supplements using HPLC/UPLC, HPTLC, CE, GC-MS, LC-MS, GC-FID, ICP-MS techniques; chemical fingerprinting and standardization of marker or active compounds in botanicals; analysis of drugs and their metabolites in biological samples (blood, saliva and urine).

Dr. Theodore R Sana has received PhD in molecular Pharmacology of Interleukin2 and its receptors from Dartmouth Medical School in 1995. He is presently a senior research scientist at Agilent Technologies. Since 2007 he has been working on developing metabolomics applications for LC/MS and GC/MS platforms for this newly formed business

He is interested in using his experience in transcriptomics, proteomics and metabolomics to help advance integrated applications (solutions, software and hardware) for systems biology that can help facilitate the testing of hypothetical metabolic models that will ultimately drive a comprehensive mathematical description of metabolism.

He received PhD in Bioanalytical Chemistry and Enzymology and MSc in Chemistry, Department from Belarussian State University Minsk

bacterial and actinomycete cells; purification of endogenous and recombinant proteins. Detailed knowledge of chromatographic media.
Hands-on experience with biotechnology (general methods of DNA cloning and mutation, plasmid isolation and purification, protein overexpression in bacteria). Basic methods in microbiology. Expression and isolation of isotope-labeled proteins. 
Isolation and characterization of enzymatic activities. Development of enzymatic assays, determination of kinetic parameters; isolation and characterization of metabolites resulting from enzyme-substrate reactions. Wide experince in the use of radioisotopes (synthesis and manipulation of radioactive compounds; obtaining and purification of radiolabelled substrates). 
Supervision of analytical staff in the laboratories. Extensive teaching experience.

Vanga R.Reddy received PhD from University of Berne, Switzerland, and MS from University of Hyderabad HCU Campus, India and BSc&BEd from Osmania University Campus, India.

Nanotechnology, Colloidal & Analytical Chemistry,Optoelectronics, Energy Harvesting and Storage, Spectroscopy,Microfluidics, Drug Delivery & Diagnostics,catalysis

Dr. Fagen Zhang received his PhD from University of Illinois at Chicago in 2000 Currently he is working as research scientist in the department of toxicology and environmental research consulting at The Dow Chemical Company. He is serving the ILSI International Life Science Institute HESI Health and Environmental Science Institute DNA Adducts Project Committee. He has also served the grant review committee of the National Center for Complementary and Alternative Medicine NCCAM/NIH the Office of Dietary Supplements ODS/NIH and NCI to review different grant applications. He has authored 40 research articles

Bioanalytical Chemistry, Drug Metabolism, Toxicology, and Pharmacokinetics/Toxicokinetics.

Lakshmy Nair is a Research Scientist in the Medication Delivery department of Baxter Healthcare where she is responsible for analytical method development, validation to support a number of formulation products In her role. she has led the analytical team to develop numerous analytical methods using HPLC/UHPLC with various detection mechanisms such as UV ELSD CAD and MS; for surfactants polymers and drug analyses Before joining Baxter she was a Senior Research Scientist at Apotex Corporation and prior to that an Instrumentation Product Development Chemist at Alltech Associate currently known as Grace Davison At Alltech Lakshmy pioneered HPLC and ion chromatography IC and was involved in developing many ionexchange stationary phases suppressors conductivity detectors and sample preparation products Lakshmy has 18 publications in various peer reviewed journals one patent and presented approximately 50 papers in various symposiums in the field of liquid chromatography She has been invited to speak at various seminars and has been a guest reviewer for Journal of Chromatography and Journal of Pharmaceutical and Biomedical Analysis Lakshmy has been a member of the abstract screening committee for the APQ Analysis and Pharmaceutical Quality session of annual AAPS meetings. Her areas of expertise are various liquid chromatographic separation techniques including reversed phase normal phase sizeexclusion ion exchange HILIC and UHPLC She is an expert in aerosolbased detectors suppressor based and nonsuppressor based conductivity detectors as well.

HPLC/UHPLCIon ChromatographyLC-MSAerosol-based detectorsLiquid Chromatographic method development Application of various chromatographic separation/detection techniques for real world samples.

Dr. Zeping Hu has received his PhD in National University of Singapore during the period of 2003-2008. Currently he is working at Biological Separations Mass Spectrometry of Pacific Northwest National Laboratory. He is serving as a reviewer of several reputed journals like Drug Metabolism Disposition Pharmaceutical Research, Journal of Pharmaceutical Sciences, Journal of Chromatography B Analytical Methods Current Pharmacogenomics and Personalized Medicine and Drug Healthcare and Patient Safety. He has authored 15 research articles,books. He is a member of American Association of Pharmaceutical Scientists, Singaporean Society for Mass Spectrometry American Association for Cancer Research, the Metabolomics Society and World Federation of Chinese Medicine Societies.

Analytical techniques, metabolomics, pharmaceutics and pharmacology.

Yang hu done his PhD in Chemistry at Wesleyan University Connecticut USA and  MS in Analytical Chemistry at The Chinese Academy of Sciences Beijing China and  BS in Pharmaceutical Sciences Peking University, Beijing Medical University Beijing China.

structure-activity relationships through designing and synthesizing a series of depsipeptides, and evaluating their substrate specificity or inhibitory potency towards beta-lactamases or DD-peptidases, in comparison with penicillins and peptides.

He obtained PhD in Biochemistry and Chemistry from University Notre Dame post doctoral training at California Institute of Technology in cell biology and immunology and executive MBA degree from Rutgers University with concentration in Finance. He was an assistant professor at University of Tennessee before joining pharmaceutical industry. He is Associate Director of Biologics the Third Party Management in BristolMyers Squibb Prior to BristolMyers Squibb. he was a Director in Analytical and Formulation Development at Medarex a senior scientist at OrthoBiotech a Johnson and Johnson Company and a scientist at Biogenex. He has authored more than 40 publications in journals over 80 abstracts invited speakers in multiple national and international conferences and workshops. He was recipient of Bernard Zussman Lectureship in 2007 University of Tennessee. He is serving as an editorial member of several reputed journals like J Chromatography B, Biotechnology and Bioengineering, J Cell Proliferation and J International Analytical Chemistry,

Protein separation, characterization, validation, project management.

Dr. Davies is an Associate Professor of Pharmaceutical Sciences College of Pharmacy Washington State University in Pullman and Director of the Pharmaceutical Sciences Graduate Program. He received his BSc in Pharmacy from the University of Alberta in 1991 and a PhD in 1996 from the Faculty of Pharmacy and Pharmaceutical Sciences From 1996 to 1998. He completed a postdoctoral fellowship in Pharmacology Therapeutics at the Faculty of Medicine University of Calgary and then joined the faculty of Pharmacy in 1998 at the University of Sydney as a lecturer and subsequently the College of Pharmacy at Washington State University in 2002 Research interests have included pharmacokinetics and pharmacodynamics of NSAIDs with special emphasis on gastrointestinal and renal toxicity the pharmaceutics of glucocorticoids and the pharmacometrics of flavonoids and stilbenes as well as novel approaches in drug delivery In particular Dr Davies has developed novel chromatographic HPLC methods for analysis of chiral flavonoids Over 135 research papers have been published since 1991 Teaching pharmacokinetics and preclinical and clinical research and assay method developed continue to be the focus of the research program of Dr Davies laboratory

Pharmacometrics of Anti-inflammatory / Anti-Cancer Drugs, Phytochemicals and Orthopedic Implants variety of sample analyses, including atomic absorption spectrophotometry, high performance liquid chromatography, specializing in HPLC/MS analyses, including: Bioanalytical Sample Analysis, Quantitative Analysis, Pharmacokinetic Analysis, High-Throughput Drug Discovery, Analytical Methods Development and Validation, Structure Elucidation including Metabolite Identification and Stability Impurity Indentification.

Novartis Institutes for Biomedical Research, Translational Sciences DMPK/DMBAUSEH 4353123, One Health Plaza

Nanotechnology, Colloidal & Analytical Chemistry.

Pfizer Global Research and Development, Pharmacokinetics Dynamics and Metabolism Biomarkers Group1 Burtt Road Andover

Nanotechnology, Global Research and Development.

Dr. Uma K Aryal received his PhD from Kyushu University of Japan in 2006 and worked as a Natural Science and Engineering Research Council of Canada NSERC Visiting Fellow at National Research Council of Canada Plant Biotechnology Institute during the period of May 2006 to June 2009. He joined Pacific Northwest National Laboratory Richland WA as a Research Associate in July 2009. He is a member of the International Biotechnology Society American Society for Mass Spectrometry and Canadian Society for Mass Spectrometry

His research interest is to use proteomics and mass spectrometry approaches to determine the underlying network that govern cellular processes in cyanobacteria, vascular plants (Arabidopsis thaliana) and white-rot fungus, and apply this knowledge for bio-fuel and/or environmental bioremediation research. Uma has a collective experience of working over 8 years in the field of proteomics and mass spectrometry and has used Cyanobacteria (Cyanothece sp.), Arabodopsis thaliana, Phanerochaete chrysosporium as research model organisms.

Prof. Edward Yu has received his PhD in Physical Chemistry from the University of Michigan during the period of 19911997. Currently he is working as an Associate Professor in the Department of Chemistry and Department of Physics and Astronomy at Iowa State University. He has authored over 30 research article, books. He is a member of the AAAS ACS BPS and ASM

X-ray crystallography, structure and function of membrane proteins, multi-drug resistance in bacteria.

John Gregory Marshall receivd PhD from University of Waterloo currently working as Associate Professor at Ryerson University.

Analytical BiochemistryClinical Proteomics ImmunologyProteomics Proteome Research.

DrNorio YasuiFurukori MD PhD now is an Associate professor of Neuropsychiatry Graduate School of Medicine Hirosaki University and a secretary of Japanese Society of Clinical Neuropsychopharmacology a committee member of Japanese Society of Clinical Neuropsychopharmacology Japanese Society of Clinical Pharmacology Japanese Research Society of Schizophrenia and Japanese Society of Psychiatry Diagnoses He got his PhD in Clinical Psychopharmacology at Hirosaki University And Dr Norio YasuiFurukori got the a Research Award Paul Janssen Award form Japanese Society of Clinical Neuropsychopharmacology in 2001 2002 2004 2005 2006 2007 2008 and 2010 and a Research Award form Hirosaki University in 1998 and 2006Currently Dr Norio YasuiFurukori’ researches focus on the clinical pharmacology in Neuropsychiatric disorders Dr Norio YasuiFurukori studies on drug metabolism and side effect of antipsychotics such as metabolic syndrome hyperprolactinemia and sexual dysfunction

Clinical pharmacology, Clinical Psychopharmacology.

Dr. Gianfranco Mamone has received PhD from University of Naples currently working as researcher at Institute of Food Science and Technology CNR Avellino Italy

Biological application: Mass spectrometry, food proteomic, identification and characterization of proteins.

Dr. Jerry Heng  was appointed Lecturer in Chemical Engineering at Imperial College London in 2007 and currently heads the Surfaces and Particle Engineering Laboratory wwwimperialacuk/spel JH obtained a PhD in Chemical Engineering from Imperial College London in 2006 and a B Eng in Chemical Engineering 1st class honours from Universiti Teknologi Malaysia UTM in 2002

Dr Jerry Heng (JH) was appointed Lecturer in Chemical Engineering at Imperial College London in 2007 and currently heads the Surfaces and Particle Engineering Laboratory (www.imperial.ac.uk/spel). JH obtained a PhD in Chemical Engineering from Imperial College London in 2006 and a B. Eng in Chemical Engineering (1st class honours) from Universiti Teknologi Malaysia (UTM) in 2002.

My research interests include synthesis, surface modification, self-assembly of materials at nanometer scale to address the problems in the field of biomedical and clean energy, including disease detection and treatment, drug delivery, catalysis, electrocatalysis and photoconversion technology.

Dr. Naushad has completed his PhD in Analytical Chemistry at the age of 26 years from Aligarh Muslim University India He has been selected as the post doctoral research fellow at Malaya University Malaysia Currently he is working as Assoc Professor in King Saud University Riyadh Saudi Arabia. He has received the scholarships from UGC India California Washington DC and Michigan. He is the author of more than 28 publications including book chapters and review papers His research area is Composite ion exchange materials Ion selective electrodes and Analytical separation techniques He is serving as an editorial board member and reviewer of several reputed scientific journals.

Microbalance, surface plasmon resonance spectroscopy, photonics.

Dr. Prashant Kole is currently associated with PKPD Core Facility School of Pharmacy Queens University Belfast UK. After completing his bachelor and masters degree in Pharmacy Dr. Prashant joined Pharmacy Group at Birla Institute of Technology and Science Pilani India as a faculty and also received his PhD Pharmacokinetics and Biopharmaceutics in year 2006. He has received number of grants and consultancy projects from industries involving variety of analytical and bioanalytical techniques. He has number of publications to his credit in peer reviewed international journals wrote many invited review articles and also has authored book chapter Dr Prashant has authored more than 50 editorial articles for various pharmacy magazines and websites. He is also a recipient of many academic and research awards Apart from his academic research and administrative involvements Dr. Prashant is also acting as a reviewer for many journals including Journal of Pharmaceutical Sciences Drug Discovery Today Nanomedicines to name few. He is also an editorial member of International Journal of Community Pharmacy Dr. Prashant has also been speaker and resource person at various conferences workshops and symposia

Dr. Prashant research interests include bioanalysis of drugs in small volume biomatrices (plasma/serum, whole blood, urine, saliva and tissues), novel sample preparation techniques and pre-clinical & clinical pharmacokinetics. His current research at PKPD Core Facility is focused on strategic development of Dried Blood Spot (DBS) bioanalytical methods and its applications in paediatric Population Pharmacokinetics studies.

Dr. Douglas J Morrison has received PhD from University of Strathclyde, and Post Graduate Certificate in Academic Practice University of Glasgow and BSc Hons Chemistry with Medicinal Chemistry University of Glasgow

precursor at the correct physiological site i.e. the colon for studies of bacterial metabolism,Carbohydrate metabolism: Exploiting natural isotopic abundance variances (C3 vs. C4 plant carbohydrates) and enrichment studies to determine the fate of dietary carbohydrates through digestion and fermentation and the impact of these processes on health and disease. Gut bacteria in health and disease: Development of in vitro and in vivo stable isotope methods to probe the function and activity of bacteria within the gut in health and disease. Non-invasive 13C breath tests: Design and use of novel 13C labelled substrates to probe physiological function in vivo. Compound-specific isotope analysis: Development of GC and LC based methods for online compound specific isotope analysis. Functional metabolomics: Development of instrumental platforms for analysis of multiple, isotopically labelled metabolites and design of tracers to probe the flux through targeted metabolic pathways in biological system.

Dr. John Timms received his PhD in Biochemistry from the University of Oxford UK in 1995. Currently he is a Lecturer/Group Leader in Cancer Proteomics at the EGA Institute for WomenHealth at University College London UK. He has authored 46 research articles/books on proteomic techniques and their application in cancer and cell signalling research. He is a member of the UCL Institute for Women Health Academic Board and Management Group the UCL Proteomics Platform Technology Development Group the British Association for Cancer Research the European Association for Cancer Research and a member of the British Society for Proteomics Research Dr. Timms research has been supported by the UK Medical Research Council Cancer ResearchUK Association for International Cancer Research EU Framework Programme 6 EMF Biological Research Trust Eve Appeal Gynaecological Cancer Research Trust and private companies

Dr. Timms conducts basic and translational cancer research through the integration of proteomic, genomic and molecular biology techniques. His group has established several proteomic platforms and applied these for profiling of clinical samples and cell models with the aim of improving proteomic coverage, sensitivity and quantitative accuracy. Proteomic platforms and their applications include: high-throughput protein/peptide extraction and MALDI-TOF MS profiling of unique serum collections for ovarian, breast, pancreatic and biliary tract cancer biomarker discovery; 2D-DIGE/MS-based expression profiling applied to tissue, cell model and serum protein fractions to identify candidate markers of breast and ovarian cancer, intermediates in growth factor signalling and proteins involved in tumour suppression and stress responses; incorporation of stable isotopic and isobaric labelling methods (SILAC, TMT), 2D-LC separations and phosphopeptide enrichment into proteomic workflows for biomarker discovery and functional characterisation. These advanced methods are being employed on several projects aimed at cancer biomarker discovery and validation and the characterisation of the molecular and cellular events associated with tumourigenesis.

Dr. Gopal Chandra Ghsoh has received his PhD in Urban and Environmental Engineering from Kyoto University Japan in 2009. Currently he is working as a research fellow in the Research Center for Environmental Quality Management RCEQM Kyoto University Japan. Since 2006 his research has focused on the analysis and fate of organic pollutants using LC/MS based technologies such as pharmaceuticals and personal care products PPCPs and endocrine disrupting chemicals EDCs in various kinds of environmental matrices

Application of LC/MS for trace analysis of environmental pollutantsAnalysis of organic pollutants in environmental matricesFate of organic pollutants in natural and engineered ecosystemAnalysis, fate and removal of Pharmaceuticals and personal care products (PPCPs) in natural and engineered ecosystemWater and wastewater treatment technologiesWater quality analysis.

Dr. Diana Poli has received his PhD in Prevention Sciences in 2007 at the University of Parma. She worked as researcher at the Occupational and Environmental Medicine Dept of Clinical Medicine Nephrology and Health Sciences University of Parma Parma 1998-2001. Currently she is working as researcher at the Laboratory of Industrial Toxicology of the University of Parma Clinical Medicine Nephrology and Health Sciences Department and at the National Institute of Occupational Safety and Prevention ISPESL From 2008. she acutes working also as a consultant in chemical risk assessment in working place and in forensic sciences She is an expert in breath analysis lung cancer disease and in Mass Spectrometry She is serving as selected referee for several international scientific journals She has collaborated in several Italian and European scientific projects and also collaborated in one project supported by the US NIH She has authored of more than 40 scientific research articles and coauthor of the Mass Spectroscopy Handbook John Wiley and Sons She is a member of Italian Chemical Society SCI – Mass Spectrometry Division and also of the Group of Italian Forensic Toxicologists GIFT which belongs to the Società Italiana di Medicina Legale e delle Assicurazioni SIMLA

Occupational and environmental medicine and health, risk assessment and chemical analyses, pulmonary disease, toxicology, forensic sciences, mass spectrometry, analytical techniques.

Degree in Medicine and Surgery 110/110 at the University of Naples, 1988 Board in Obstetrics and Gynaecology 70/70 cum laude University of Naples 1992

High-performance liquid chromatography, DNA sequencing, gel electrophoresis, NMR, IR spectroscopy, lasers, optic design, fluorescence and absorption spectroscopy, and wet chemistry methods.

Dr. Lorenzo Nissen start is research career in 2005 after earning a fellowship for a sixmonth predoctoral research at the Institute of Agrochemistry and Food Technologies of CSIC in Valencia Spain Then in 2008 he has received his PhD in Microbial Ecology from Bologna University Dept of Agroenvironmental Sciences and Technologies Faculty of Agriculture in CoAdvisorship with Maribor University Dept of Biochemistry Faculty of Medicine under the project “PathogenCombata of the 6th EU Framework Programme In 2010 he has successfully completed his postdoctoral studies in Bologna University in Molecular Microbiology studying Host/Microbe Interactions in different scenarios under the project Quality Low Input Foods of the 6th EU Framework Programme Under this frame at the end of 2009. He won a mobility research fellowship to conduct a project at the University of Zurich Dept of Oral Biology Faculty of Medicine Currently he is working as a senior contract researcher in Bologna University under the project Crops2Industry of the 7th EU Framework Programme He has reviewed research articles for journals like Nat Product Commun Int J Food Microbiol Ann Microbiol He has authored almost ten research articles from 2005 and has presented several works at more than twenty international congresses He is a member of ESDO European Society for Digestive Oncology from 2010 For two times 2007 and 2010 he was honoured by UEGF United Europe Gastroenterology Federation with a prize for basic science work for his presentations made at the UEGW United Europe Gastroenterology Week congresses

The topic which he repute the most exciting is the study of Microbe/Host Interaction, in particular on the strategies that different microbial populations adopt to compete each other for the substrate. He had investigated on the challenge between pathogens and probiotic bacteria over different scenarios as: that of the GIT or that of the oral cavity. He gained expertise over many protocols of molecular biology and over the broad range of applications of Real Time PCR technique. Another topic which he is applying with results is that of antimicrobials and the ability of natural products to inhibit bacterial pathogens and attenuate their virulence.

Dr. Peter J Silk received his PhD in 1970 from the University of London UK After a postdoctoral fellowship at UNB Chemistry Fredericton he worked as Assistant Professor in Chemistry at UNB he spent 27 years in the provincial research organization in NB Canada as the Head of Chemical and Biotechnology from which he retired in 2003. Currently he is working in a new career as an Insect Chemical Ecologist with Natural Resources Canada where he working on insect chemical communication research. He is serving as an editorial board member of The Acadian Entomological Society and has authored over 100 research articles, book chapters. He is a member of International Society of Chemical Ecology and The Entomological Society of America. He was made a Fellow of the Chemical Institute of Canada in 1984

His research interests are in insect semiochemistry, environmental chemistry, organic chemistry, fungal metabolism and natural halogenations systems where he is well published. His interests involve using GC/MS and LC/MS systems in isolating, identifying and synthesizing insect pheromones and kairomones for detection and management strategies.

Dr. Brian Buckley received his BS in chemistry from the University of New Hampshire in 1983 his PhD in analytical chemistry from North Carolina State University in 1989 and completed a posdoctoral fellowship at Oak Ridge National Laboratory. Currently he is working as the Executive Director of Laboratories at the Environmental and Occupational Health Sciences Institute at Rutgers University Dr Buckley is an NIEHS Center Facility Core Director a member of the graduate faculty of the Rutgers Environmental Sciences Department and the Joint Graduate Program in Toxicology as well as the UMDNJ School of Public health He is serving as an editorial member of several reputed journals like Journal of Environmental and Public Health and the Global Journal of Analytical Chemistry He has authored more than 50 research articles/book chapters He is a member of the American Chemical Society and the Society of Applied Spectroscopy and was honored as the Virgil Payne Award for Outstanding Chemical Service Achievement and has served on multiple review panels for NIH and EPA FIFRA Currently his research focus is on analytical mass spectrometric methods development and modification to measure environmental contaminants and their metabolites. His research has focused on innovative analytical techniques such as Microwave Assisted Solvent Extraction MASE solid phase micro extraction SPME and metal speciation to measure contaminants in multiple media His research projects include; using synthetic biofluid extractions for estimating bioavailability measurement of unregulated organic contaminants such as pharmaceuticals in drinking water quantifying arsenic species in human urine and extraction of BPA from tissue

Department of Therapeutic Drug Monitoring, Institute of Pharmacology, University of Cologne

Drug Monitoring, Pharmacology.

I have extensive expertise in protein chemistry and glycobiology and have been working on the basic and translational research of galectins. In my postdoctoral research, I studied on the structurefunction aspects of the lectins, particularly galectins from vertebrates and invertebrates. The structurefunction studies enabled me to predict the type of endogenous ligands for a particular galectin. As a coinvestigator on a NIHfunded grant, I identified and characterized the zebrafish galectin repertoire, which showed remarkable structural similarities with mammalian galectins. The two proto type galectins, Drgal1L2 and Drgal1L4 are found specifically expressed in the notochord and are involved in muscle cell development including heart. As PI on three federal NIH and DOD and one nonfederal university grants, I have been studying on human galectins, particularly on application and manipulation of galectin3 for the diagnosis and prevention of cancers. In addition, I successfully administered the projects including research protections, budget, and collaboration and produced peerreviewed publications. In summary, I have a demonstrated record of successful and productive research projects in an area of lectincarbohydrate interactions.

My research interest has been in the area of basic and translational research of the carbohydrate-binding proteins (called lectins). Particularly, I am interested in structure, function and regulation of galectins (a family of beta-galactoside-binding lectins) and their interactions with the carbohydrates that mediate cell-cell and cell-extracellular matrix (ECM) interactions during normal and cancer development such as prostate and breast cancers. The prostate cancer cells differentially express several members of galectins, which alter normal cell-cell and cell-ECM interactions during cancer development. We have discovered a novel isoform of galectin-8 that may be relevant to prostate cancer cell proliferation. We have demonstrated cytosine methylation in galectin promoter in cancerous prostate, which may account for the differential expression of galectins during cancer development. Differential expression of galectin repertoire and identification of cytosine methylation of galectin gene promoters in normal and tumor prostate tissues have enabled us to develop a methylation-specific PCR based sensitive assay for early diagnosis of prostate cancer in biological fluids such as serum and urine. In another project, natural carbohydrate inhibitors of galectin are being employed to prevent breast cancer metastasis.

Dr. Wei Huang earned his Ph.D. in Organic Chemistry from Shanghai Institute of Materia Medica, Chinese Academy of Sciences in 2005, followed by one year as a postdoctoral fellow at University of Utah and four years as a research associate at University of Maryland School of Medicine. Since July 2010, he has been appointed an assistant professor position of biochemistry at Institute of Human Virology, University of Maryland School of Medicine.

Dr. Wei Huang works in the areas of carbohydrate chemistry and glycobiology in terms of carbohydrate-based vaccine for HIV and other infectious diseases. Glycan shield on the HIV envelope glycoprotein gp120 has been proved to be the epitope of broadly neutralizing antibody 2G12. To design and synthesize novel carbohydrate-based conjugates mimicking the HIV glycan shield is an HIV vaccine strategy for eliciting 2G12-like neutralizing antibody. Dr. Huang’s another project focuses on glycophosphatidylinositol (GPI)-based vaccine studies against GPI-related infectious diseases, such as malaria, trypanosome, etc.

Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Infectious Diseases, University of Torino Amedeo di Savoia Hospital.

Pharmacogenetics, Clinical Pharmacology.

Cell separation
Capillary electrophoresis for enzyme activity study
Single cell analysis
Targeted anti-cancer drug delivery

Dr. Esra Kupeli Akkol has received his PhD in Gazi University during the period of 2004. Currently, she is working as Associate professor in Gazi University, Ankara, Turkey. She has authored several research articles. she has honored with Scientific Encouragement Award by Academy of Pharmacy

Our main focus was on bio-assay guided isolation of active constituents, as well as synthesized compounds. I worked on anti-inflammatory, antinociceptive, anti-rheumatic activity, wound healing assessment of folk remedies